In vitro, parthenolide exerts its tumour suppressive effect in CRC by suppressing the expression of migration/invasion-related proteins, such as E-cadherin, Snail, MMP-2, MMP-9, and cyclooxygenase-2 (COX-2) [175]. The gene discussed is PTGS2; the disease is colorectal carcinoma.